Acasti Pharma Forms Scientific Advisory Board and Appoints Two Leading Cardiovascular Disease Experts Mar 8, 2017
Acasti Pharma Announces Proposed Private Placement of Convertible Debentures and Amended Proposed Offering of Units Feb 2, 2017
Acasti Pharma Builds Intellectual Property Portfolio with Newly Issued U.S. Patent for CaPre Oct 26, 2016
